HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section
Dr. Getz develops and applies advanced methods to enable epidemiologic research that aims to optimize the treatment and supportive care of children with cancer by balancing the therapeutic benefits and toxicity risks with an emphasis in cardio-oncology.
Dr. Getz's research is focused on the treatment and supportive care of children and young adults with cancer, and on understanding and balancing the associated therapeutic benefits and toxicity risks, with an emphasis in cardio-oncology. Her overarching research goal is to develop and apply advanced epidemiologic methods to existing data resources in creative ways to enable observational research studies that will impact practice. She hopes that her research will address treatment and outcome disparities, and improve both clinical outcomes and quality of life for pediatric cancer patients across diagnoses, during treatment, and into survivorship.
Her Alex's Lemonade Stand Foundation Young Investigator Award evaluates risk factors for cardiac dysfunction during AML therapy and assesses novel early indicators of cardiotoxicity to identify patients at the highest risk before they progress to overt irreversible cardiomyopathy.
Her NHLBI K01 leverages the strengths of multiple complementary data resources including the clinical trial data, administrative billing data, echocardiographic studies, and large volume electronic health record data to address important questions across the cardiotoxicity risk continuum.
Education and Training
MPH, Boston University (Epidemiology), 2009
PhD, Boston University (Epidemiology), 2014
Postdoctoral Fellow, Children's Hospital of Philadelphia(Pediatric Cancer Epidemiology), 2014-2016
Titles and Academic Titles
Assistant Professor of Epidemiology
Society for Epidemiologic Research, 2010-
Society for Pediatric and Perinatal Epidemiologic Research, 2009-
American Society of Clinical Oncology, 2014-
Children's Oncology Group , 2014-
GlaxoSmithKline R&D Award for Pharmacodynamic Modeling and Simulation, 2003
Lilly Champion Award for Expertise in Population Pharmacokinetic Modeling, 2004
Boston University Reproductive, Perinatal, and Pediatric Epidemiology Training Program (T32 HD052458), 2009-2013
NIH, NICHD, and CIHR Joint Summer Institute in Reproductive and Perinatal Epidemiology, 2012
Society of Epidemiologic Research First Prize Methods Abstract, 2014
Heart House Roundtable, Cardio-Oncology: Risk Assessment & Management Strategies, 2019
Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia
- Alex's Lemonade Stand Foundation Young Investigator Award
- PI: Getz
Early Treatment-Related Cardiotoxicity and Subsequent Outcomes in Pediatric Acute Myeloid Leukemia: an Assessment of Development, Progression, and Mitigation
- NIH K01-HL143153
- PI: Getz